骨髓内皮细胞调控糖尿病中的髓系细胞生成
研究利用链脲佐菌素、高脂饮食和db/db三种糖尿病小鼠模型,发现糖尿病时骨髓内皮细胞Cxcl12表达下降,造血干/祖细胞增殖增强,循环髓系细胞增多。内皮细胞Egfr信号缺失会降低血管生成素-1表达,加剧髓系细胞生成,并加速动脉粥样硬化、延迟伤口愈合。
要点
- 糖尿病时骨髓内皮细胞Cxcl12表达下降,造血干/祖细胞增殖增强。
- 内皮细胞Egfr信号缺失降低血管生成素-1,加剧髓系细胞生成。
- 内皮Egfr缺失加速动脉粥样硬化并延迟糖尿病伤口愈合。
核心结论
- 糖尿病中骨髓内皮细胞参与骨髓造血失调,内皮Egfr信号是限制造血干/祖细胞增殖和髓系细胞生成的保护性通路。
研究设计与样本
- 研究采用链脲佐菌素、高脂饮食和db/db三种小鼠糖尿病模型,检测白细胞、造血干/祖细胞及骨髓内皮细胞。
- 通过流式细胞术和表达谱分析骨髓内皮细胞,并构建内皮特异性Egfr敲除小鼠(Cdh5CreEgfrfl/fl)。
主要发现
- 糖尿病小鼠造血干/祖细胞增殖增强,循环髓系细胞数量增加。
- 糖尿病小鼠骨髓内皮细胞Cxcl12表达减少,饮食诱导糖尿病小鼠内皮细胞Egfr信号相关基因富集。
- 内皮特异性Egfr缺失小鼠表现造血干/祖细胞增殖增强和髓系细胞生成增加,内皮血管生成素-1表达下降。
- 糖尿病Cdh5CreEgfrfl/fl小鼠皮肤伤口中炎性髓系细胞积聚更多,伤口闭合显著延迟。
- Cdh5CreEgfrfl/fl小鼠动脉粥样硬化加速,主动脉斑块更大且炎症更重。
临床怎么用
- 提示骨髓内皮细胞Egfr信号可能作为糖尿病血管并发症的潜在干预靶点。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
BACKGROUND: Diabetes mellitus is a prevalent public health problem that affects about one-third of the US population and leads to serious vascular complications with increased risk for coronary artery disease. How bone marrow hematopoiesis contributes to diabetes mellitus complications is incompletely understood. We investigated the role of bone marrow endothelial cells in diabetic regulation of inflammatory myeloid cell production. METHODS: In 3 types of mouse diabetes mellitus, including streptozotocin, high-fat diet, and genetic induction using leptin-receptor-deficient db/db mice, we assayed leukocytes, hematopoietic stem and progenitor cells (HSPC). In addition, we investigated bone marrow endothelial cells with flow cytometry and expression profiling. RESULTS: In diabetes mellitus, we observed enhanced proliferation of HSPC leading to augmented circulating myeloid cell numbers. Analysis of bone marrow niche cells revealed that endothelial cells in diabetic mice expressed less Cxcl12, a retention factor promoting HSPC quiescence. Transcriptome-wide analysis of bone marrow endothelial cells demonstrated enrichment of genes involved in epithelial growth factor receptor (Egfr) signaling in mice with diet-induced diabetes mellitus. To explore whether endothelial Egfr plays a functional role in myelopoiesis, we generated mice with endothelial-specific deletion of Egfr (Cdh5CreEgfrfl/fl). We found enhanced HSPC proliferation and increased myeloid cell production in Cdh5CreEgfrfl/fl mice compared with wild-type mice with diabetes mellitus. Disrupted Egfr signaling in endothelial cells decreased their expression of the HSPC retention factor angiopoietin-1. We tested the functional relevance of these findings for wound healing and atherosclerosis, both implicated in complications of diabetes mellitus. Inflammatory myeloid cells accumulated more in skin wounds of diabetic Cdh5CreEgfrfl/fl mice, significantly delaying wound closure. Atherosclerosis was accelerated in Cdh5CreEgfrfl/fl mice, leading to larger and more inflamed atherosclerotic lesions in the aorta. CONCLUSIONS: In diabetes mellitus, bone marrow endothelial cells participate in the dysregulation of bone marrow hematopoiesis. Diabetes mellitus reduces endothelial production of Cxcl12, a quiescence-promoting niche factor that reduces stem cell proliferation. We describe a previously unknown counterregulatory pathway, in which protective endothelial Egfr signaling curbs HSPC proliferation and myeloid cell production.
引用
- Hoyer FF, Zhang X, Coppin E, et al. Bone Marrow Endothelial Cells Regulate Myelopoiesis in Diabetes Mellitus. Circulation. 2020. PMID: 32316750. doi:10.1161/CIRCULATIONAHA.120.046038
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。